Global GMP Cell Banking Market by Type (Mammalian Cell, Microbial Cell, Insect Cell, Others), By Application (Biopharmaceutical Companies, Contract Manufacturing Organizations) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “GMP Cell Banking Market research report which is segmented by Types (Mammalian Cell, Microbial Cell, Insect Cell, Others), By Applications (Biopharmaceutical Companies, Contract Manufacturing Organizations), By Players/Companies WuXi AppTec, Charles River Laboratories International, Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., Paragon Bioservices”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | GMP Cell Banking Market Research Report |
| By Type | Mammalian Cell, Microbial Cell, Insect Cell, Others |
| By Application | Biopharmaceutical Companies, Contract Manufacturing Organizations |
| By Companies | WuXi AppTec, Charles River Laboratories International, Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., Paragon Bioservices |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 246 |
| Number of Tables & Figures | 173 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global GMP Cell Banking Market Report Segments:
The market is segmented by Type Mammalian Cell, Microbial Cell, Insect Cell, Others and By Application Biopharmaceutical Companies, Contract Manufacturing Organizations.
Some of the companies that are profiled in this report are:
- WuXi AppTec
- Charles River Laboratories International
- Eurofins Scientific
- Merck KGaA
- Lonza Group Ltd
- SGS Ltd
- ViruSure GmbH
- Austrianova
- Goodwin Biotechnology Inc.
- Paragon Bioservices
GMP Cell Banking Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the GMP Cell Banking Market
Overview of the regional outlook of the GMP Cell Banking Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The GMP Cell Banking Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of GMP Cell Banking Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Mammalian Cell
2. Microbial Cell
3. Insect Cell
4. Others
7. By Application:1. Biopharmaceutical Companies
2. Contract Manufacturing Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GMP Cell Banking Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the GMP Cell Banking Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GMP Cell Banking Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GMP Cell Banking Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GMP Cell Banking Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GMP Cell Banking Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GMP Cell Banking Market Size & Forecast, 2018-2028
4.5.1 GMP Cell Banking Market Size and Y-o-Y Growth
4.5.2 GMP Cell Banking Market Absolute $ Opportunity
Chapter 5 Global GMP Cell Banking Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GMP Cell Banking Market Size Forecast by Type
5.2.1 Mammalian Cell
5.2.2 Microbial Cell
5.2.3 Insect Cell
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GMP Cell Banking Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GMP Cell Banking Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Manufacturing Organizations
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GMP Cell Banking Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GMP Cell Banking Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GMP Cell Banking Analysis and Forecast
9.1 Introduction
9.2 North America GMP Cell Banking Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GMP Cell Banking Market Size Forecast by Type
9.6.1 Mammalian Cell
9.6.2 Microbial Cell
9.6.3 Insect Cell
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GMP Cell Banking Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Contract Manufacturing Organizations
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GMP Cell Banking Analysis and Forecast
10.1 Introduction
10.2 Europe GMP Cell Banking Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GMP Cell Banking Market Size Forecast by Type
10.6.1 Mammalian Cell
10.6.2 Microbial Cell
10.6.3 Insect Cell
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GMP Cell Banking Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Contract Manufacturing Organizations
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GMP Cell Banking Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GMP Cell Banking Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GMP Cell Banking Market Size Forecast by Type
11.6.1 Mammalian Cell
11.6.2 Microbial Cell
11.6.3 Insect Cell
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GMP Cell Banking Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Contract Manufacturing Organizations
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GMP Cell Banking Analysis and Forecast
12.1 Introduction
12.2 Latin America GMP Cell Banking Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GMP Cell Banking Market Size Forecast by Type
12.6.1 Mammalian Cell
12.6.2 Microbial Cell
12.6.3 Insect Cell
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GMP Cell Banking Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Contract Manufacturing Organizations
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GMP Cell Banking Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Type
13.6.1 Mammalian Cell
13.6.2 Microbial Cell
13.6.3 Insect Cell
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Contract Manufacturing Organizations
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GMP Cell Banking Market: Competitive Dashboard
14.2 Global GMP Cell Banking Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 WuXi AppTec
14.3.2 Charles River Laboratories International
14.3.3 Eurofins Scientific
14.3.4 Merck KGaA
14.3.5 Lonza Group Ltd
14.3.6 SGS Ltd
14.3.7 ViruSure GmbH
14.3.8 Austrianova
14.3.9 Goodwin Biotechnology Inc.
14.3.10 Paragon Bioservices
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GMP Cell Banking Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GMP Cell Banking Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GMP Cell Banking Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GMP Cell Banking Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GMP Cell Banking Market Size & Forecast, 2018-2028
4.5.1 GMP Cell Banking Market Size and Y-o-Y Growth
4.5.2 GMP Cell Banking Market Absolute $ Opportunity
Chapter 5 Global GMP Cell Banking Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GMP Cell Banking Market Size Forecast by Type
5.2.1 Mammalian Cell
5.2.2 Microbial Cell
5.2.3 Insect Cell
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GMP Cell Banking Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GMP Cell Banking Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Manufacturing Organizations
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GMP Cell Banking Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GMP Cell Banking Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GMP Cell Banking Analysis and Forecast
9.1 Introduction
9.2 North America GMP Cell Banking Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GMP Cell Banking Market Size Forecast by Type
9.6.1 Mammalian Cell
9.6.2 Microbial Cell
9.6.3 Insect Cell
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GMP Cell Banking Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Contract Manufacturing Organizations
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GMP Cell Banking Analysis and Forecast
10.1 Introduction
10.2 Europe GMP Cell Banking Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GMP Cell Banking Market Size Forecast by Type
10.6.1 Mammalian Cell
10.6.2 Microbial Cell
10.6.3 Insect Cell
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GMP Cell Banking Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Contract Manufacturing Organizations
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GMP Cell Banking Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GMP Cell Banking Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GMP Cell Banking Market Size Forecast by Type
11.6.1 Mammalian Cell
11.6.2 Microbial Cell
11.6.3 Insect Cell
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GMP Cell Banking Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Contract Manufacturing Organizations
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GMP Cell Banking Analysis and Forecast
12.1 Introduction
12.2 Latin America GMP Cell Banking Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GMP Cell Banking Market Size Forecast by Type
12.6.1 Mammalian Cell
12.6.2 Microbial Cell
12.6.3 Insect Cell
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GMP Cell Banking Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Contract Manufacturing Organizations
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GMP Cell Banking Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Type
13.6.1 Mammalian Cell
13.6.2 Microbial Cell
13.6.3 Insect Cell
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GMP Cell Banking Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Contract Manufacturing Organizations
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GMP Cell Banking Market: Competitive Dashboard
14.2 Global GMP Cell Banking Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 WuXi AppTec
14.3.2 Charles River Laboratories International
14.3.3 Eurofins Scientific
14.3.4 Merck KGaA
14.3.5 Lonza Group Ltd
14.3.6 SGS Ltd
14.3.7 ViruSure GmbH
14.3.8 Austrianova
14.3.9 Goodwin Biotechnology Inc.
14.3.10 Paragon Bioservices
Segments Covered in the Report
The global GMP Cell Banking market has been segmented based on
By Types
The global GMP Cell Banking market has been segmented based on
By Types
- Mammalian Cell
- Microbial Cell
- Insect Cell
- Others
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- WuXi AppTec
- Charles River Laboratories International
- Eurofins Scientific
- Merck KGaA
- Lonza Group Ltd
- SGS Ltd
- ViruSure GmbH
- Austrianova
- Goodwin Biotechnology Inc.
- Paragon Bioservices
Our Clients
Related Reports
Some other reports from this category!
